Trials / Not Yet Recruiting
Not Yet RecruitingNCT06920186
Infiltration or Nerve Blocks in Addition to Adductor Canal Block
Comparison of the Benefit of Peripheral Nerve Quadri-block Versus Adductor Canal Block + Surgical Infiltration in Total Knee Arthroplasty
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the analgesic efficacy of this quadruple sensory block compared with the currently recommended procedure (adductor canal block + infiltration).
Detailed description
In addition to the adductor canal block, this quadruple block incorporates : 1. the block of the lateral cutaneous nerve of the thigh (or femoral-cutaneous nerve), which is a collateral sensory branch of the posterior part of the lumbar plexus. 2. IPACK (Infiltration between Popliteal Artery and Capsule of Knee), designed as a motor-sparing technique (targeting the sensory articular branches of the sciatic nerve and avoiding the motor branches of the tibial and fibular nerves), is particularly effective on posterior pain. 3. obturator nerve block, a mixed nerve originating from the anterior part of the lumbar plexus. It divides into two branches: anterior, which innervates the adductor longus, adductor brevis and gracilis muscles, and posterior, which innervates the medial part of the knee joint and the posteromedial part of the thigh. It provides sensitivity to the medial aspect of the thigh.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Analgesia | 1- Real Adductor canal block + surgical infiltration and sham of femoro-cutaneous block + obturator block + IPACK block with physiological serum |
| PROCEDURE | Analgesia | 2- Real Adductor canal block + femoral-cutaneous block + obturator block + IPACK block and sham of surgical infiltration with physiological serum |
Timeline
- Start date
- 2026-01-14
- Primary completion
- 2027-01-01
- Completion
- 2027-02-01
- First posted
- 2025-04-09
- Last updated
- 2026-01-15
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06920186. Inclusion in this directory is not an endorsement.